Corbus Pharmaceuticals Holdings Inc. Stock Climbs 5.4%, Outperforms Peers
Dow Jones2026/07/23 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rallied 5.4% to $9.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.2% to 25,137.69 and Dow Jones Industrial Average falling 1.0% to 51,711.65.
Corbus Pharmaceuticals Holdings Inc. closed 54.7% below its 52-week high of $20.56, which the company reached on October 20th.
The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 0.2% to $5.36, Fortress Biotech Inc. fell 3.4% to $3.43, and Viking Therapeutics Inc. fell 5.15% to $35.39.
Trading volume totaled 638,462, compared to the 50-day average of 530,252.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 23, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Indonesia to open trading at planned commodity bourse on January 4, official says
SPX Technologies Completed Acquisition of FIS Water for About $410 M in Cash >SPXC
--Kilroy Realty Keeps Quarterly Dividend at $0.54 a Share, Payable Oct. 14 to Shareholders of Record Sept. 30
Crypto prices
More
